SG11202104849UA - A peripheral blood mirna marker for diagnosis of non-small cell lung cancer - Google Patents

A peripheral blood mirna marker for diagnosis of non-small cell lung cancer

Info

Publication number
SG11202104849UA
SG11202104849UA SG11202104849UA SG11202104849UA SG11202104849UA SG 11202104849U A SG11202104849U A SG 11202104849UA SG 11202104849U A SG11202104849U A SG 11202104849UA SG 11202104849U A SG11202104849U A SG 11202104849UA SG 11202104849U A SG11202104849U A SG 11202104849UA
Authority
SG
Singapore
Prior art keywords
diagnosis
lung cancer
small cell
peripheral blood
cell lung
Prior art date
Application number
SG11202104849UA
Other languages
English (en)
Inventor
Ruiyang Zou
Dan Su
He Cheng
Lisha Ying
Lihan Zhou
Original Assignee
Mirxes Hangzhou Biotechnology Co Ltd
Zhejiang Cancer Hospital
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mirxes Hangzhou Biotechnology Co Ltd, Zhejiang Cancer Hospital filed Critical Mirxes Hangzhou Biotechnology Co Ltd
Publication of SG11202104849UA publication Critical patent/SG11202104849UA/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/118—Prognosis of disease development
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/178—Oligonucleotides characterized by their use miRNA, siRNA or ncRNA

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Hospice & Palliative Care (AREA)
  • Biophysics (AREA)
  • Oncology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
SG11202104849UA 2018-11-12 2019-11-11 A peripheral blood mirna marker for diagnosis of non-small cell lung cancer SG11202104849UA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CN201811336972.2A CN109207599A (zh) 2018-11-12 2018-11-12 一种用于非小细胞肺癌诊断的外周血miRNA标志物
PCT/CN2019/117176 WO2020098607A1 (en) 2018-11-12 2019-11-11 A peripheral blood miRNA marker for diagnosis of non-small cell lung cancer

Publications (1)

Publication Number Publication Date
SG11202104849UA true SG11202104849UA (en) 2021-06-29

Family

ID=64995188

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11202104849UA SG11202104849UA (en) 2018-11-12 2019-11-11 A peripheral blood mirna marker for diagnosis of non-small cell lung cancer

Country Status (9)

Country Link
US (1) US20230287504A1 (zh)
EP (1) EP3880849A4 (zh)
JP (1) JP2022507252A (zh)
KR (1) KR20210104037A (zh)
CN (3) CN109207599A (zh)
AU (1) AU2019378289A1 (zh)
PH (1) PH12021551087A1 (zh)
SG (1) SG11202104849UA (zh)
WO (1) WO2020098607A1 (zh)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109207599A (zh) * 2018-11-12 2019-01-15 觅瑞（杭州）生物科技有限公司 一种用于非小细胞肺癌诊断的外周血miRNA标志物
CN111239389A (zh) * 2020-01-20 2020-06-05 复旦大学附属中山医院 区分肝细胞肝癌和正常人的自身抗体标志物及其筛选方法
CN112063716A (zh) * 2020-09-09 2020-12-11 南通大学 一种评估肺癌耐药和转移发生风险的检测试剂盒
CN112695095A (zh) * 2021-01-11 2021-04-23 中国医科大学 一种外周血miRNA肺癌诊断标志物组合及其检测试剂盒
CN114606319A (zh) * 2021-04-16 2022-06-10 博尔诚（北京）科技有限公司 用于检测肺癌的标志物、试剂盒及系统
CN113862355A (zh) * 2021-09-27 2021-12-31 苏州健雄职业技术学院 一组肺癌相关的miRNA生物标志物及其应用
CN115125304B (zh) * 2022-06-29 2023-07-04 宁波大学 一种用于非小细胞肺癌早期诊断或检测的ceRNA调控网络及其应用

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7943318B2 (en) * 2006-01-05 2011-05-17 The Ohio State University Research Foundation Microrna-based methods and compositions for the diagnosis, prognosis and treatment of lung cancer
CN101684489A (zh) * 2008-09-25 2010-03-31 中国科学院上海生命科学研究院 肺癌的一种诊断标志物
EP2336353A1 (en) * 2009-12-17 2011-06-22 febit holding GmbH miRNA fingerprints in the diagnosis of diseases
CN101638656B (zh) * 2009-08-28 2011-05-11 南京医科大学 一种与非小细胞肺癌预后相关的血清/血浆miRNA标志物及其应用
CN101921759B (zh) * 2010-09-08 2013-05-29 南京医科大学 一种与宫颈癌及其癌前病变相关的血清/血浆miRNA标志物及其应用
CN102321760A (zh) * 2011-08-26 2012-01-18 泸州医学院附属医院 一种非小细胞肺癌标志物及应用
CN102965441A (zh) * 2012-12-06 2013-03-13 苏州市思玛特电力科技有限公司 microRNA基因miR-1291用于预测乳腺癌预后的用途
US11053545B2 (en) * 2015-09-08 2021-07-06 The Translational Genomics Research Institute Biomarkers and methods of diagnosing and prognosing mild traumatic brain injuries
CN109207599A (zh) * 2018-11-12 2019-01-15 觅瑞（杭州）生物科技有限公司 一种用于非小细胞肺癌诊断的外周血miRNA标志物

Also Published As

Publication number Publication date
EP3880849A1 (en) 2021-09-22
EP3880849A4 (en) 2022-08-24
KR20210104037A (ko) 2021-08-24
JP2022507252A (ja) 2022-01-18
CN109207599A (zh) 2019-01-15
AU2019378289A1 (en) 2021-06-10
CN110656181A (zh) 2020-01-07
WO2020098607A1 (en) 2020-05-22
PH12021551087A1 (en) 2021-12-06
US20230287504A1 (en) 2023-09-14
CN117867105A (zh) 2024-04-12
CN110656181B (zh) 2024-03-05

Similar Documents

Publication Publication Date Title
SG11202104849UA (en) A peripheral blood mirna marker for diagnosis of non-small cell lung cancer
HK1248141A1 (zh) 為t細胞療法而調理患者的方法
EP3180075A4 (en) Integrated electromyographic clinician programmer for use with an implantable neurostimulator
EP3177739A4 (en) Microrna biomarker for the diagnosis of gastric cancer
EP3359689A4 (en) DIAGNOSTIC USE OF GENETIC SIGNATURE FOR EVALUATING PROSTATE CANCER TREATMENT STRATEGIES
EP3302507A4 (en) DIAGNOSTIC METHODS FOR T-CELL THERAPY
EP3092006A4 (en) Targeted therapy for small cell lung cancer
EP3128917A4 (en) System and method for assessing a cancer status of biological tissue
EP3597733A4 (en) THREE-DIMENSIONAL CULTURE OF PRIMARY CANCER CELLS USING TUMOR TISSUE
IL270717A (en) Biomarkers for the diagnosis of lung cancer
EP3393372A4 (en) SYSTEM AND METHOD FOR INCREASING A TRANSVERSAL SECTION AREA OF A BODY LIGHT
EP3221003A4 (en) Therapy system for transcutaneous in-vivo tissue engineering
EP3365063A4 (en) METHOD OF SCORING A SAMPLE COMPRISING A TUMOR TISSUE
HK1253082A1 (zh) 診斷乳腺癌的方法
EP3359696A4 (en) DIAGNOSTIC TEST FOR URINE MONITORING OF BUBBLE CANCER
HK1257345A1 (zh) 使用了血液細胞的組織、內臟器官的製作方法
GB201908591D0 (en) Methods for cancer diagnosis
IL289348A (en) A new diagnostic marker for pancreatic cancer
EP3391885A4 (en) THERAPEUTIC AGENT AGAINST BREAST CANCER
ZA202107342B (en) Chiauranib for treatment of small cell lung cancer
EP3318632B8 (en) Marker for heterogeneity of cancer tissue, and use thereof
GB201814350D0 (en) Diagnosis of cancer
IL246580B (en) Cancer diagnostic methods using mirna ratios
EP3607066A4 (en) PROCEDURE FOR DETECTION OF LUNG CANCER
PL3580567T3 (pl) Metoda in vitro w diagnostyce raka płuc